Bioeconomy Capital, a Venture Fund based in Seattle, focuses on Seed, Series A, and Series B stage investments in various sectors including Manufacturing, AgTech, ClimateTech, RestaurantTech, Impact Investing, Infrastructure, and Life Science. With a portfolio of companies like Riffyn, Bioeconomy Capital has made 15 investments to date. Partnered by Robert Carlson, the fund aims to accelerate the biotechnology revolution by supporting early-stage companies. For more information, visit their website at www.bioeconomycapital.com or reach out to Robert Carlson via email at rob@bioeconomy.capital.